| Name | Title | Contact Details |
|---|
NanoHybrids specializes in research and commercialization of nanotechnology-based products that enhance diagnosis and therapy for cancer and other diseases through enhanced molecular imaging and profiling. Our molecular imaging nanoparticles enhance contrast in vitro and in vivo across multiple biomedical imaging modalities. We are the leading provider of silica-coated gold nanoparticles optimized for photoacoustic (optoacoustic) imaging. With conjugation services we provide nanoparticles with high specificity for targeted cell receptors and tailored to individual applications. Our nanoparticles improve signal strength and allow real time imaging of functional biology. Interested in learning how we are using nanotechnology to drive advances in the life-sciences? Want learn more about our research, products, or services? Contact us, and let`s talk.
Viveve provides women low risk, high reward medical procedures that promote personal health and wellness.
At Accure, we are wholly committed to developing revolutionary solutions to provide a long-lasting, durable response to acne. We know that acne can have a devastating social, psychological, physical, and economic impact on patients around the world. We are pioneering transformative solutions that will answer this unmet need and have a positive and profound impact on patients and providers worldwide.
Best Medical International is a Springfield, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.